Thomas Hofmann
Chief Executive Officer bij Aumapharma, Inc.
Profiel
Thomas Hofmann is the founder of Aumapharma, Inc., QrumPharma, Inc. He previously worked as a Principal at Windtree Therapeutics, Inc. and Corus Pharma, Inc. He also served as the Chief Medical Officer & Head-Clinical Development at Vectura GmbH from 2013 to 2014.
Additionally, he held a Principal position at Pulmopharm GmbH.
Dr. Hofmann's education includes a doctorate degree from the University of Giessen, which was conferred in 1994.
Actieve functies van Thomas Hofmann
| Bedrijven | Functie | Begin |
|---|---|---|
| Aumapharma, Inc. | Chief Executive Officer | - |
QrumPharma, Inc.
 QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Chief Executive Officer | - |
Eerdere bekende functies van Thomas Hofmann
| Bedrijven | Functie | Einde |
|---|---|---|
| MANNKIND CORPORATION | Chief Tech/Sci/R&D Officer | 01-01-2024 |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Chief Tech/Sci/R&D Officer | 01-07-2014 |
| WINDTREE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| Pulmopharm GmbH | Corporate Officer/Principal | - |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Opleiding van Thomas Hofmann
| University of Giessen | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Health Technology |
| Pulmopharm GmbH | |
| Aumapharma, Inc. | |
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Health Technology |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Health Technology |
